Listen Here

| |

Actionable
Takeaways

Supply depth before demand scale prevents unit economics collapse:

Ian's experience across three labor marketplaces reinforced one principle: excess supply is recoverable, excess demand is catastrophic. With too much demand and insufficient supply, you're "spending a bunch of money to acquire these demand users, but you're not able to fulfill the supply side. So now they're churning out at a high clip, they're going somewhere else. And now it drives up your CAC across the marketplace and reduces your lifetime value." In two-sided marketplaces, founders must resist investor pressure to show demand-side revenue before supply reliability is proven—the temporary revenue bump destroys long-term unit economics.

ICP clarity requires live market data, not pre-launch assumptions:

Toothio launched targeting private practices (shorter sales cycles, lower barriers, faster learning) before discovering DSOs were the actual ICP through usage cohorts showing materially higher volume and retention. Ian was explicit: "Once we got into it, we realized...the true ICP is going to be our group practices." The tactical framework: establish presence across plausible segments, instrument everything, collect 1-2 quarters of behavioral data, then redirect resources to wherever retention and expansion metrics are strongest. This data-driven ICP discovery prevents premature optimization around the wrong customer profile.

Hire senior enterprise operators when you have validation plus clear TAM:

Toothio broke conventional early-stage wisdom by hiring a Chief Commercial Officer and SVP Sales—roles typically considered "top-heavy"—because Ian had validated product-market fit and identified a concentrated enterprise opportunity (hundreds of DSOs). The result: "Next thing you know, we're in front of five or six of the top eight or ten DSOs in the country." The decision framework: if you have (1) proven unit economics, (2) clear product-market fit signals, and (3) an enterprise TAM with established relationship networks, senior hires with category Rolodexs can compress multi-year enterprise sales cycles into quarters. Without all three conditions, follow conventional wisdom and stay lean.

Outsider economic analysis creates differentiated value propositions:

Ian's non-dental background enabled him to "look at the dental office P&L and the core drivers of production with a completely neutral lens and realize that there was a lot of waste." He quantified what insiders hadn't: recruiting costs up 100%+ in five years, dental turnover among the highest of any U.S. industry, and the compounding cost of cancelled patient days (immediate production loss + 20% patient churn × $10-15K lifetime values). This economic framing repositioned Toothio from "staffing vendor" to strategic finance partner. The pattern: outsiders should weaponize their fresh perspective by conducting rigorous economic impact analysis that category incumbents haven't done, then speak to buyers in CFO language rather than operational features.

Industry association involvement is enterprise distribution, not brand marketing:

Ian credited local and national dental association sponsorships as "the catalyst to get us on the radar of some of the bigger orgs early" because associations created credibility signals plus network effects at scale. In relationship-driven B2B categories with strong professional associations (dental, legal, accounting, healthcare), sponsorship generates repeated exposure to concentrated decision-maker populations and warm introduction paths that cold outbound can't replicate. Founders should map the association landscape in year one, treat it as a primary distribution channel with measurable pipeline contribution, and staff it with team members who can build genuine relationships—not just write checks.

Conversation
Highlights

 

How Toothio Built Marketplace Economics by Breaking Conventional Startup Rules

Ian Prendergast had built labor marketplaces before. At Qwick, he launched 15 hospitality staffing markets. At Steady Install, he scaled light industrial contractor placement to five cities in 2020. When a dentist mentioned a staffing crisis during a 2021 golf round, Ian saw pattern recognition, not opportunity.

Then he researched the numbers.

97% of dentists reported staffing as their primary volume constraint. 95% cited extreme recruiting difficulty. Meanwhile, 75% of hygienists prioritized schedule flexibility above everything else—practice type, patient demographics, clinical work didn’t matter.

The structural mismatch was severe. Dental services were growing at 10.5% annually while 40% of the workforce had departed in 2020. In a recent episode of Category Visionaries, Ian, now Co-Founder and CEO of Toothio, shared how marketplace fundamentals from other verticals translated into dental—and where conventional startup wisdom proved catastrophically wrong.

 

Why Supply-First Prevents Unit Economics Collapse

Most marketplace founders chase paying customers first. Revenue signals traction. Investors want to see demand validation. The pressure to show top-line growth is intense.

Ian inverted the sequence entirely.

“We started recruiting,” he explains. “We would be advertising on various job boards. We would get involved in local and regional groups like hygiene groups, assisting groups, office management clubs.” Months of supply-side development preceded the first practice customer.

The logic emerged from painful experience across three marketplaces: “If you have a ton of demand, not enough supply, well, all of a sudden you’re spending a bunch of money to acquire these demand users, but you’re not able to fulfill the supply side. So now they’re churning out at a high clip, they’re going somewhere else. And now it drives up your CAC across the marketplace and reduces your lifetime value.”

Excess supply is recoverable—you can throttle recruitment spending and let utilization catch up. Excess demand destroys the business model. You’re burning capital to acquire customers who immediately churn because you can’t deliver the core promise. CAC spikes while LTV collapses.

The principle extends beyond marketplaces. In any business where reliability drives retention, proving you can deliver consistently matters more than proving someone will pay. Quality and reliability were Toothio’s only defensible product, and both required supply depth before demand scale.

 

How Usage Data Reveals Your Actual ICP

Toothio launched targeting private dental practices. The thesis made sense: shorter sales cycles, lower risk, faster iteration cycles. Classic bottoms-up validation.

After collecting behavioral data across segments, a different picture emerged. “We realized, okay, there certainly is a need on the private practice side of this market,” Ian says. “But the true ICP is going to be our group practices.”

DSOs—dental service organizations ranging from small groups to enterprise roll-ups like MB2 and Heartland—showed fundamentally different usage patterns. Higher booking volume. Stickier retention. More strategic about how they deployed flexible staffing to manage seasonality and turnover.

The tactical framework Ian used: establish presence across plausible segments, instrument everything, collect 1-2 quarters of cohort data, then redirect resources toward wherever retention and expansion metrics are strongest.

Private practices weren’t a mistake—they served a specific purpose. Lower barriers to entry meant faster market education. Shorter sales cycles meant rapid feedback on product-market fit. They were the right customers for validation, just not the right customers for scale.

This sequencing matters. Premature enterprise focus without product validation burns time in long sales cycles before you know if the product works. But staying in SMB too long after data shows enterprise fit caps growth potential.

 

When Senior Hires Compress Enterprise Cycles

With DSO validation established, Ian made a decision that typically triggers investor pushback: he hired a Chief Commercial Officer and Senior VP of Sales.

“Historically, early stage is not exactly a great thing,” he acknowledges. “Investors try to shine you away from that. Like, hey, we don’t want a top heavy org. You want a bunch of ICs. You want to be doing a lot of still founder led sales.”

The result validated the bet. “All of a sudden we brought in a couple big wigs in the dental space. They started making introductions. Next thing you know, we’re in front of five or six of the top eight or ten DSOs in the country.”

The decision framework was specific: validated product-market fit, clear unit economics, and a concentrated enterprise TAM where relationship networks created asymmetric advantages. Without all three conditions, conventional wisdom holds—stay lean, keep founder-led sales, hire ICs.

But when those conditions exist, senior operators with category Rolodexs can compress multi-year relationship-building into quarters. The top 10 DSOs weren’t discoverable through cold outbound. They required warm introductions from operators who had sold into them before and understood their procurement processes.

 

How Outsider Analysis Creates Differentiated Positioning

Not being from dental created an obvious credibility problem. Ian solved it systematically: “I knew I was smart enough to know that I didn’t know. So the pieces that we needed to put around us were people that were SMEs, people that understood the space even down to people that ran our orientations.”

Toothio hired hygienists to conduct orientation sessions. They brought in advisors who had sold into DSOs. They embedded dental professionals across operations to build category expertise.

But the outsider lens also unlocked something insiders had completely missed.

“I was able to come in and look at the dental office P&L and the core drivers of production with a completely neutral lens and realize that there was a lot of waste,” Ian explains. He conducted the economic analysis the industry hadn’t done: recruiting costs had increased over 100% in five years. Dental turnover ranked among the highest of any U.S. industry—higher than retail, approaching hospitality levels.

Then he quantified the compounding cost of unstaffed days. Each unstaffed hygienist day cost $1,560 in lost production. But the second-order effect was worse: “You’re going to lose two out of those 10 patients that you’re going to see that day. They’re going to go somewhere else with their lifetime values are $10 to $15,000.”

The math: $1,560 immediate production loss + (20% patient churn × $12,500 average LTV) = $4,060 total cost per unstaffed day. Multiply across seasonality, sick days, and turnover cycles, and the annual impact for a single hygienist position approached $50,000+.

“We were able to work backwards and create this very tangible ROI,” Ian says. “That then allowed us to come back to our customers and establish ourselves as subject matter experts and speak their language.”

This economic framing repositioned Toothio from staffing vendor to strategic finance partner speaking CFO language. It’s the kind of analysis that requires distance from industry orthodoxy—insiders were too close to the problem to see the full P&L impact.

 

Why Associations Function as Enterprise Distribution

In relationship-driven B2B categories, finding concentrated access to decision-makers without burning budget on low-conversion outbound is challenging. Ian found it through industry associations.

“Getting involved in local and national associations was a big deal from a credibility factor for us,” he explains. “Once we sponsored a few events and we sponsored a few association events and we got our name out there, I think that was kind of the catalyst to get us on the radar of some of the bigger orgs early.”

Associations work because they create repeated exposure in trusted contexts. When DSO executives see Toothio sponsoring the regional dental conference, speaking on workforce panels, and actively participating in industry conversations, it generates credibility that cold emails can’t replicate.

The network effects compound. Association involvement led to conversations with other vendors who made introductions to shared customers. It positioned Toothio as category participants, not just vendors selling into the category.

For B2B founders in industries with strong professional associations—legal, accounting, healthcare, financial services—this represents primary distribution infrastructure. The playbook: map the association landscape early, treat sponsorship as pipeline investment with measurable contribution, and staff it with team members building genuine relationships.

 

Building Moats Over Distribution Channels

Ian sees the labor marketplace as foundation, not destination. “I think labor marketplace in general is fantastic, especially right now because you’re building a distribution channel and you’re building usually a hyper engaged distribution channel that is not going to be automated out with AI.”

The next phase: layering SaaS over the distribution channel to increase switching costs. “It’s about layering software over the top. What kind of additional value? Looking at the RCM, revenue cycle management, looking at other softwares that are being used in the practice and then how can we consolidate that into one clean, easy to use platform and add business value and ultimately build our moat.”

The pattern is familiar—Toast with restaurant POS, Shopify with e-commerce infrastructure, Procore with construction management. Build distribution through a high-frequency transaction product, then expand into adjacent software that benefits from the data and relationships the core business generates.

Toothio’s national expansion is already underway, using AI agents to eliminate the geographic constraints that traditionally limit labor marketplaces. For an industry where 97% of practices cite staffing as their primary growth limiter, the TAM remains structural and massive.

The bigger lesson isn’t about dental staffing. It’s about when to break conventional startup wisdom. Supply before demand prevented unit economics collapse. Data-driven ICP discovery avoided premature optimization. Senior enterprise hires compressed sales cycles when conditions warranted. Outsider economic analysis created differentiated positioning.

Sometimes the best move is ignoring the playbook entirely.

 

Recommended Founder
Interviews

Brett Kleger

CEO of Datacubed Health

Brett Kleger, CEO of Datacubed Health: $43 Million Raised to Revolutionize Clinical Trial Data Collection

Todd Zion

Founder of Akston Biosciences

Todd Zion, Founder of Akston Biosciences: From a $500M Exit to Pioneering Biotech Innovation in Pet Health

Kourosh Davarpanah

Co-Founder and CEO of Inato

Kourosh Davarpanah, Co-Founder and CEO of Inato: Over $35 Million Raised to Build the Future of Clinical Trials

Kyle Kiser

CEO of Arrive Health

Kyle Kiser, CEO of Arrive Health: Over $40 Million Raised to Improve the Value of Healthcare Through Informed Decision-Making

Brock Leonti

CEO & Co-Founder of Prescribe FIT

Brock Leonti, CEO & Co-Founder of Prescribe FIT: $15 Million Raised to Build the Future of Orthopedic Care

Michael Chang

Mastering Market Fit in AI: Insights from Michael Chang, Director of Marketing at ArteraAI

Thomas Knox

CEO & Founder of VitVio

Thomas Knox, CEO & Founder of VitVio: $10 Million Raised to Transform Surgical Operations Through AI-Powered Automation

Nabeel Kaukab

Founder and CEO of Phamily

How Phamily built an eight-figure ARR healthcare company without discounting: The subsidized R&D approach | Nabeel Kaukab ($25M Raised)

Cesar Herrera

CEO and Co-Founder of Yuvo Health

Cesar Herrera, CEO and Co-Founder of Yuvo Health: $28 Million Raised to Revolutionize Healthcare Access

Dipanwita Das

CEO and Co-Founder of Sorcero

Dipanwita Das, CEO and Co-Founder of Sorcero: Over $20 Million Raised to Power Medical Affairs Teams of the Future

Joe Gagnon

CEO of 1upHealth

Joe Gagnon, CEO at 1upHealth: Over $75 Million Raised to Build the Future of Healthcare Data

Mike Desjadon

CEO of Anomaly

Why Anomaly avoids annual curiosity revenue (ACR) — and you probably should to | Mike Desjadon ($30M Raised)

Derek Streat

Co-Founder & Chief Executive Officer of Dexcare

Derek Streat, CEO of Dexcare: $110 Million Raised to Help Health Systems to Find Time for the Best Care

Mark Lehmkuhle

CEO & Founder of Epitel

Mark Lehmkuhle, CEO & Founder of Epitel: $20 Million Raised to Build the Future of Brain Health Monitoring

Kevin Flyangolts

CEO and Founder of Aclid

Kevin Flyangolts, CEO & Founder of Aclid: $4 Million Raised to Build the Future of Biosecurity

Kristen Valdes

CEO & Founder of B.well

Kristen Valdes, CEO & Founder of B.well: $100 Million Raised to Reimagine the Healthcare Experience

David King Lassman

Founder of GigXR

David King Lassman, Founder of GigXR: $7 Million Raised to Bring Immersive Learning to Healthcare

Viral Patel

Founder and CEO of Radish Health

Viral Patel, CEO of Radish Health: $5 Million Raised to Connect Employees with a Better Healthcare Experience

Armon Sharei

CEO & Founder of Portal

Armon Sharei, CEO & Founder of Portal: $5 Million Raised to Power the Future of Cell Engineering

Teodor Grantcharov

Founder of Surgical Safety Technologies Inc.

How Surgical Safety Technologies targeted the most challenging customers first (massive hospitals) | Teodor Grantcharov

Rafid Fadul

CEO and Co-Founder of Zivian Health

Rafid Fadul, CEO and Co-Founder of Zivian Health: $3 Million Raised to Power the Future of Compliant Healthcare Collaborations

Cody Simmons

CEO of DermaSensor

Cody Simmons, CEO of DermaSensor: $36 Million Raised to Build the First AI-Powered Skin Cancer Detection Tool for Primary Care

Rishi Nayyar

CEO and Co-Founder of PocketHealth

Rishi Nayyar, CEO and Co-Founder of PocketHealth: $22.5 Million Raised to Power the Future of Medical Image Sharing

Daniel West

CEO of Prospection

Daniel West, CEO of Prospection: $36 Million Raised to Build the Future of Patient-Centric Intelligence

James Bates

CEO and Founder of AdviNOW Medical

James Bates, CEO and Founder of AdviNOW Medical: $24 Million Raised to Build the Future of AI-Powered Healthcare

Samson Magid

Co-Founder and CEO of HealthSnap

Samson Magid, Co-Founder and CEO of HealthSnap: Over $12 Million Raised to Build the Future of Remote Patient Monitoring

Matthew Stoudt

CEO and Founder of AppliedVR

Matthew Stoudt, CEO and Founder of AppliedVR: Over $70 Million Raised to Build the Future of Chronic Pain Relief

Veer Gidwaney

CEO & Founder of Ansel Health

Veer Gidwaney, CEO & Founder of Ansel Health: $50 Million Raised to Transform Supplemental Health Insurance

Itzik Cohen

Co-Founder and CEO of PayZen

Itzik Cohen, Co-Founder and CEO of PayZen: $240 Million Raised to Build the Future of Affordable Health Care

Elad Ferber

CEO & Co-Founder of Synthpop

Elad Ferber, CEO & Co-Founder of Synthpop: $8 Million Raised to Build the Future of Healthcare Administration with AI

Hala Borno

Founder and CEO of Trial Library

Hala Borno, Founder and CEO of Trial Library: $5M Raised to Improve Patient Recruitment and Diversity in Oncology Clinical Trials

Marshall Darr

CEO & Co-Founder of StretchDollar

How StretchDollar drives leads from LLM search | Marshall Darr

Torben Nielsen

CEO & Co-Founder of Uptiv Health

Torben Nielsen, CEO of Uptiv Health: $7.5M Raised to Build the Future of Infusion Therapy Through Technology-Enabled Retail Centers

Joseph Schneier

CEO of Trusty Care

Joseph Schneier, CEO of Trusty Care: $13+ Million Raised to Shape the Future of Medicare

Brandon Young

CMO of Garner Health

Why Marketing Lost Its Craft (And How AI Could Force It Back)

Henry O’Connell

CEO & Founder of Canary Speech

Henry O’Connell, CEO & Founder of Canary Speech: $26 Million Raised to Build the Future of Vocal Biomarker Technology

Jocelyn Nowak

Marketing & Sales Enablement Lead of FIGUR8

Integrity-Driven Marketing: FIGUR8’s Path to 3,000+ Clinics

Daniel Lambert

CEO of PathologyWatch

Daniel Lambert, CEO of PathologyWatch: Over $50 Million Raised to Build the Future of Digital Pathology

Michael Gorton

Founder of Teladoc

Teladoc Founder Michael Gorton on the Early Days of Pioneering the Telemedicine Category (And What’s He’s Up to Next)

Nick Soman

CEO & Founder of Decent

Nick Soman, CEO & Founder of Decent: $43 Million Raised to Build the Future of Direct Primary Care

Gregory Stein

CEO of Shadowbox

How Shadowbox evolved it’s ICP from desperate labs to health systems with 500-1,000 community providers | Gregory Stein

Trenor Williams

CEO and Co-Founder of Socially Determined

Trenor Williams, CEO and Co-Founder of Socially Determined: $34 Million Raised to Build the Social Risk Intelligence Category

Matt Renfro

Co-Founder & CEO of Lynx

Matt Renfro, CEO of Lynx: $17.5 Million raised to Bring Modern Fintech to Healthcare

Vicky Demas

CEO of Identifeye Health

Vicky Demas, CEO of identifeye HEALTH: $90 Million Raised to Power the Future of Retinal Imaging

Danny Freed

CEO & Founder of Blueprint

Danny Freed, CEO & Founder of Blueprint: $13.7 Million Raised to Build the Future of Therapist Enablement

Khaled Boukadoum

Founder of Torch Dental

Khaled Boukadoum, Founder of Torch Dental: $49.5 Million Raised to Transform Dental Supply Management Through Digital Innovation

Stacy Edgar

CEO and Co-Founder of Venteur

Stacy Edgar, CEO & Co-Founder of Venteur: $7.6 Million Raised to Build the Future of Health Insurance

Aasim Saeed

CEO and Founder of Amenities Health

Aasim Saeed, CEO and Founder of Amenities Health: $10 Million Raised to Build the Future of Patient Engagement

Dimitrios Skaltsas

CEO & Co-Founder of Intelligencia AI

Dimitrios Skaltsas, CEO & Co-Founder of Intelligencia AI: $15.5 Million Raised to Build the Future of Drug Development

Austin McChord

CEO of Casana

Austin McChord, CEO of Casana: Over $46 Million Raised to Create the Future of In-Home Health Monitoring

David Berry

CEO and Founder of Valo

David Berry, CEO and Founder of Valo: Over $500 Million Raised to Build the Future of Drug Discovery

Corey Washington

Senior Marketing Manager of Amenities Health

Humanizing Healthcare Tech: Marketing Lessons from Amenities

Verena Gerhardus

Director of Growth of Nelly Solutions

How Nelly Grew 3X Through Meta Ads in Health Tech

Alfred Griffin

CEO and Co-Founder of CEO and Co-Founder

Alfred Griffin, CEO and Co-Founder of LightForce: $150 Million Raised to Power the Future of Orthodontics

Andreas Cleve

CEO and Co-Founder of Corti

Andreas Cleve, CEO and Co-Founder of Corti: $32 Million Raised to Power the Future of Patient Consultations

Richard Queen

CEO and Co-Founder of DignifiHealth

Richard Queen, CEO and Co-Founder of DignifiHealth: $7 Million Raised to Drive Better Patient Outcomes in Rural Healthcare and Beyond

Alexandra Ferraro

Head of Marketing of Intelligencia AI

Beyond Perfect: Healthcare Tech Marketing That Drives Real Revenue

Angella Gronenthal

VP of Marketing of Nice Healthcare

Ignacio Medrano

Founder & CMO of Savana

Ignacio Medrano, Founder & CMO of Savana: $44M Raised to Transform Healthcare Intelligence Through AI

Justin Dearborn

Founder & CEO of Praia Health

Justin Dearborn, Founder & CEO of Praia Health: $20 Million Raised to Build the Future of Consumer Experience in Healthcare

Jennifer Bittinger

President and Founder of Narrativa

How Narrativa leveraged COVID-19 as a market catalyst to accelerate AI adoption in pharma | Jennifer Bittinger ($2.4M Raised)

Michael Passanante

Senior Vice President of Marketing and Communications of Capital Rx

How to Build 18-Month Attribution Models That Actually Work

Senan Ebrahim

CEO & Founder of Delfina

Senan Ebrahim, CEO & Founder of Delfina: $10 Million Raised to Build the Future of Intelligent Pregnancy Care

Dr. Nan-Wei Gong

CEO and Founder of FIGUR8

Dr. Nan-Wei Gong, CEO & Founder of FIGUR8: $40 Million Raised to Build the Future of Musculoskeletal Health and Injury Data Solutions

Dr Thomas Oakley

CEO of Feedback PLC

Dr Thomas Oakley, CEO of Feedback PLC: £20 Million Raised to Build the Future of Patient Data Sharing

Trey Sutten

CEO & Co-Founder of Siftwell Analytics

Trey Sutten, CEO & Co-Founder of Siftwell Analytics: $5 Million Raised to Transform Healthcare Analytics with AI-Powered Predictions

Joshua Miller

CEO and Co-Founder of Gradient Health

Joshua Miller, CEO & Co-Founder of Gradient Health: $5.7 Million Raised to Build the Future of Medical Imaging

Amar Kendale

President and Co-Founder of Homeward

Amar Kendale, President & Co-Founder of Homeward: $70 Million Raised to Transform Rural Healthcare Through Technology

Rebecca McNeil

VP of Marketing of SureCost

Why This VP of Marketing Abandoned Paid Media Completely

Alex Zekoff

CEO and Co-Founder of Thoughtful AI

Alex Zekoff, CEO and Co-Founder of Thoughtful AI: $21 Million Raised to Power the Future of Healthcare Automation

Ben Albert

CEO & Co-Founder of Upfront Healthcare

Ben Albert, CEO & Co-Founder of Upfront Healthcare: $30 Million Raised to Power the Future of Patient Engagement

Amy Brown

CEO and Founder of Authenticx

Amy Brown, CEO and Founder of Authenticx: $28 Million Raised to Build the Future of Listening AI

Brad Kittredge

CEO & Co-Founder of Brightside

Brad Kittredge, CEO & Co-Founder of Brightside: $150 Million Raised to Build the Future of Mental Healthcare

Omer Maman

VP of Marketing of Healthee

Why AI Should Enhance, Not Replace Your Marketing Team

Dilpreet Sahota

CEO of Trek Health

Dilpreet Sahota, CEO of Trek Health: $3 Million Raised to Help Mental Health Providers Accept Insurance

Ty Allen

CEO of SocialClimb

Ty Allen, CEO of SocialClimb: $12 Million Raised to Power the Future of Healthcare Marketing